Advanced Prostate Adenocarcinoma and Androgen Deprivation Therapy. Clinical Outcomes, Risk Stratification, and Therapeutic Results

Advanced prostate adenocarcinoma presents intricate clinical challenges shaped by biological heterogeneity and evolving therapeutic demands. This volume examines patients treated with total androgen deprivation therapy in a tertiary-care hospital between 2017 and 2020, offering an observational pers...

全面介紹

Saved in:
書目詳細資料
格式: Online
語言:英语
出版: South American Publishing 2026
主題:
在線閱讀:https://directory.doabooks.org/handle/20.500.12854/176897
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!
_version_ 1869517857074708480
collection Directory of Open Access Books
description Advanced prostate adenocarcinoma presents intricate clinical challenges shaped by biological heterogeneity and evolving therapeutic demands. This volume examines patients treated with total androgen deprivation therapy in a tertiary-care hospital between 2017 and 2020, offering an observational perspective on risk stratification, biochemical response, and disease progression. Particular attention is given to prostate-specific antigen dynamics, serum testosterone levels, and the broader physiological consequences of hormonal suppression, including effects on sexual function and general health. By situating clinical findings within tumor biology and institutional practice, the study provides a grounded account of treatment monitoring and outcome interpretation in advanced prostate cancer care.
format Online
id doab-20.500.12854ir-176897
institution Directory of Open Access Books
language eng
publishDate 2026
publishDateRange 2026
publishDateSort 2026
publisher South American Publishing
publisherStr South American Publishing
record_format ojs
spelling doab-20.500.12854ir-1768972026-05-25T06:23:08Z Advanced Prostate Adenocarcinoma and Androgen Deprivation Therapy. Clinical Outcomes, Risk Stratification, and Therapeutic Results Tabares Hernández, Liorna Ferrán Fernández, Maité Gómez Areces, René Prostate cancer, Advanced prostate adenocarcinoma, Androgen deprivation therapy, Risk stratification, Prostate-specific antigen, Hormonal resistance thema EDItEUR::V Health, Relationships and Personal development::VF Family and health::VFD Popular medicine and health::VFDM Men’s health::VFDM1 Prostate health thema EDItEUR::M Medicine and Nursing Advanced prostate adenocarcinoma presents intricate clinical challenges shaped by biological heterogeneity and evolving therapeutic demands. This volume examines patients treated with total androgen deprivation therapy in a tertiary-care hospital between 2017 and 2020, offering an observational perspective on risk stratification, biochemical response, and disease progression. Particular attention is given to prostate-specific antigen dynamics, serum testosterone levels, and the broader physiological consequences of hormonal suppression, including effects on sexual function and general health. By situating clinical findings within tumor biology and institutional practice, the study provides a grounded account of treatment monitoring and outcome interpretation in advanced prostate cancer care. Published 2026-05-25T06:23:05Z 2026-05-25T06:23:05Z 2024-01-19 book 978-9915-9869-7-5 https://directory.doabooks.org/handle/20.500.12854/176897 eng application/octet-stream South American Publishing South American Publishing 10.62486/978-9915-9869-7-5 10.62486/978-9915-9869-7-5 18fbfe3b-3f91-4cf7-b6b9-18d696cb9331 978-9915-9869-7-5 South American Publishing 75 Montevideo open access
spellingShingle Prostate cancer, Advanced prostate adenocarcinoma, Androgen deprivation therapy, Risk stratification, Prostate-specific antigen, Hormonal resistance
thema EDItEUR::V Health, Relationships and Personal development::VF Family and health::VFD Popular medicine and health::VFDM Men’s health::VFDM1 Prostate health
thema EDItEUR::M Medicine and Nursing
Advanced Prostate Adenocarcinoma and Androgen Deprivation Therapy. Clinical Outcomes, Risk Stratification, and Therapeutic Results
title Advanced Prostate Adenocarcinoma and Androgen Deprivation Therapy. Clinical Outcomes, Risk Stratification, and Therapeutic Results
title_full Advanced Prostate Adenocarcinoma and Androgen Deprivation Therapy. Clinical Outcomes, Risk Stratification, and Therapeutic Results
title_fullStr Advanced Prostate Adenocarcinoma and Androgen Deprivation Therapy. Clinical Outcomes, Risk Stratification, and Therapeutic Results
title_full_unstemmed Advanced Prostate Adenocarcinoma and Androgen Deprivation Therapy. Clinical Outcomes, Risk Stratification, and Therapeutic Results
title_short Advanced Prostate Adenocarcinoma and Androgen Deprivation Therapy. Clinical Outcomes, Risk Stratification, and Therapeutic Results
title_sort advanced prostate adenocarcinoma and androgen deprivation therapy clinical outcomes risk stratification and therapeutic results
topic Prostate cancer, Advanced prostate adenocarcinoma, Androgen deprivation therapy, Risk stratification, Prostate-specific antigen, Hormonal resistance
thema EDItEUR::V Health, Relationships and Personal development::VF Family and health::VFD Popular medicine and health::VFDM Men’s health::VFDM1 Prostate health
thema EDItEUR::M Medicine and Nursing
topic_facet Prostate cancer, Advanced prostate adenocarcinoma, Androgen deprivation therapy, Risk stratification, Prostate-specific antigen, Hormonal resistance
thema EDItEUR::V Health, Relationships and Personal development::VF Family and health::VFD Popular medicine and health::VFDM Men’s health::VFDM1 Prostate health
thema EDItEUR::M Medicine and Nursing
url https://directory.doabooks.org/handle/20.500.12854/176897